The Boeing Company Stock Price Targets

Comprehensive analysis of short, mid, and long-term price targets for The Boeing Company (BA).

Back to Analysis Hub

Give me a comprehensive price target analysis for The Boeing Company (BA).

Here is the requested analysis for The Boeing Company (BA), with horizontal price target lines drawn and a comprehensive price-target analysis.

Horizontal lines drawn (Low, Median, High)

  • Low Target: 150.00 (color: #00FF00, green) from 2025-10-07 to 2025-11-06
  • Median Target: 255.00 (color: #1E90FF, blue) from 2025-10-07 to 2025-11-06
  • High Target: 287.00 (color: #FF0000, red) from 2025-10-07 to 2025-11-06

Summary of line-drawing actions

  • p1.time: 2025-10-07T00:00:00Z for all lines
  • p2.time: 2025-11-06T00:00:00Z (approximately 30 days into the future)
  • Ticker: BA

Executive Summary

  • The stock trades near $219.73 with a median analyst target of $255 and a high target of $287, implying potential upside of roughly 16% to the median and about 30% to the high over a 3–12 month horizon.
  • Structural headwinds exist: negative earnings margins (net margin around -14%), negative book value (price-to-book around -50), and a very high forward P/E (~467x) reflecting expectations of outsized, near-term earnings improvement that has not yet materialized in reported results.
  • The stock is currently trading below the 50-day moving average, suggesting near-term softness despite a historically high beta (1.47) and a broad consensus that prices could re-rate higher if earnings stabilization occurs.
  • Analyst revisions show more downgrades than upgrades in recent periods, underscoring execution or guidance risk. Nevertheless, a sizable analyst group (22) is providing upside price targets, indicating potential for a re-rating if earnings momentum materializes.

Fundamental Analysis Key metrics (selected)

  • Current price (BA): 219.73
  • Market cap: 167,018,528,768
  • Enterprise value: 196,950,917,120
  • Trailing P/E: N/A
  • Forward P/E: 467.51
  • Price to book: -50.29
  • Return on equity: N/A
  • Return on assets: -3.73%
  • Profit margins: -14.18%
  • Gross margins: -0.15%
  • Operating margins: -0.98%
  • Total cash: 22,257,999,872
  • Total debt: 55,646,999,528
  • Dividend yield: N/A
  • Five-year average dividend yield: 2.48%
  • Beta: 1.47

Notes

  • A negative price-to-book is not unusual for a balance sheet with significant intangible/obsolete asset write-downs or negative equity portions. The forward P/E implies expectations of substantial earnings acceleration that are not currently reflected in trailing results, signaling higher risk if those expectations don’t materialize.
  • Net debt (approximate) = Total debt - Total cash ≈ 33.39B, which is meaningful relative to current market capitalization and could influence valuation discipline going forward.

Earnings Analysis

Recent Earnings Summary (selected quarters)

  • 2025-06-30: Net income from continuing operations -$611,000,000; Diluted EPS -$0.92; EBITDA $609,000,000; Operating income -$268,000,000

  • 2025-03-31: Net income -$37,000,000; Diluted EPS -$0.16; EBITDA $1,250,000,000; Operating income $461,000,000

  • 2024-12-31: Net income -$3,865,000,000; Diluted EPS -$5.46; EBITDA -$2,829,000,000; Operating income -$3,770,000,000

  • 2024-09-30: Net income -$6,170,000,000; Diluted EPS -$9.97; EBITDA -$5,052,000,000; Operating income -$5,746,000,000

  • 2024-06-30: Net income -$1,439,000,000; Diluted EPS -$2.33; EBITDA -$401,000,000; Operating income -$1,100,000,000

  • Takeaway: The company has reported substantial net losses in several recent quarters, with persistent negative earnings early in 2024–2025. This backdrop helps explain the extremely positive forward P/E implied by the market, as investors price in potential future profitability improvements.

EPS Trend

  • 0q (current): -0.99774
  • 7 days ago: -0.99774
  • 30 days ago: -0.39182
  • 60 days ago: -0.37402
  • 90 days ago: -0.36782
  • +1q: 0.00346
  • 0y: -2.66529
  • +1y: 3.56791

Interpretation

  • The trailing and near-term EPS figures are negative but show a meaningful improvement trajectory into the next year (+1q and +1y values). The jump from deeply negative levels to a positive +1y projection suggests analysts are pricing in a strong earnings rebound, even as the most recent quarters remained negative.

EPS Revisions

  • 0q: upLast7days=0, upLast30days=0, downLast30days=5, downLast7Days=1
  • +1q: upLast7days=0, upLast30days=1, downLast30days=3, downLast7Days=1
  • 0y: upLast7days=0, upLast30days=0, downLast30days=5, downLast7Days=1
  • +1y: upLast7days=1, upLast30days=0, downLast30days=3, downLast7Days=0

Interpretation

  • The revisions data show more downgrades than upgrades across most horizons (particularly for 0q and 0y). The only positive tilt appears in +1y with a single upLast7days, suggesting some longer-dated optimism may exist, but near-term sentiment has been more negative.

Technical Analysis

Current price action and indicators

  • Price (as of 2025-10-06/07): 219.7
  • 50-day moving average (last values): ~224.8 (MA trending higher over the period shown, but the price remains below the MA)
  • RSI (14): ~57.2 (neutral to mildly bullish; not overbought)
  • MACD (12,26,9): Recent MACD around -2.3 with Signal around -3.1 (MACD above the signal as of the latest data, hinting at a possible near-term bullish crossover after a period of negative momentum)

Current technical posture

  • The price sits just below the 50-day MA, suggesting near-term softness or a potential test of the MA. RSI shows modest upward momentum without being overbought. MACD is negative but showing signs of flattening, which could precede a re-rating if earnings momentum stabilizes.

Analyst Consensus & Price Targets

  • Current price: 219.73
  • Target low / median / high: 150.00 / 255.00 / 287.00
  • Target mean price: 253.50
  • Number of analysts: 22

Price Target Analysis (Short, Mid, Long-Term)

Short-Term (3 months)

  • Target: Median 255 (upside ≈ 16.0% from 219.73)
  • Justification: The median and high targets imply a potential near-term re-rating if earnings momentum stabilizes and the market starts to price in a more favorable earnings trajectory. With 22 analysts covering BA, the breadth of opinion suggests a relatively robust near-term debate about the company’s trajectory.
  • Key drivers: Near-term earnings stabilization (as indicated by the EPS trend data showing a potential move toward positive EPS in the next year and the +1q EPS figure), continued backlog execution, and defense and commercial aerospace demand recovery. However, revisions remain skewed toward downgrades in the near term, which could cap immediate upside.

Mid-Term (12 months)

  • Target: Median ~255 (≈ +16% from current)
  • Justification: The market may re-rate BA on an improving earnings backdrop, progress on MAX program throughput, and potential upside from defense spending. A steady improvement in EPS trends and more positive revisions over a 12-month horizon could anchor a move toward the median target.
  • Key drivers: Sustained earnings growth, stabilization of operating margins, and successful ramp of key programs (e.g., MAX family programs and defense/space contracts). Continued cash flow generation and debt management would support a higher multiple.

Long-Term (3+ years)

  • Target: High 287 (≈ +30% from current)
  • Justification: A long-duration scenario relies on sustained earnings growth, a normalized margin profile, and a favorable backlog mix that supports continued cash generation and shareholder value creation. The 287 target provides an optimistic but credible upside if structural improvements in profitability and free cash flow occur.
  • Key drivers: Structural margin expansion, successful execution on defense/spaces ramp, and a continued recovery in the commercial aerospace cycle post-pandemic normalization.

Key Risks & Opportunities

Risks

  • Continued negative earnings trajectory or weak margin recovery (economic or cyclical headwinds for aerospace, regulatory or supply chain pressures).
  • Overhang from a negative balance sheet framework and a forward P/E that implies steep growth expectations not yet realized.
  • Analyst revisions skewed to downgrades in the near term, signaling execution or guidance risk.

Opportunities

  • Backlog strength and defense spending tailwinds could support a re-rating as earnings power returns.
  • Boeing’s MAX production stability and recovery in air travel demand could lift revenues and margins.
  • Potential capital allocation improvements and strategic partnerships could unlock value beyond base operations.

Investment Recommendation

  • Rating: Hold
  • Time horizon: 12–24 months
  • Rationale: The stock presents a potential upside to the median and high targets, driven by an improving earnings trajectory and defense/backlog catalysts. However, near-term profitability remains a critical risk, and revisions remain skewed to the downside in the near term. The current price sits below the 50-day MA, suggesting some near-term underperformance risk unless earnings momentum improves. A measured stance with active monitoring of quarterly results and revisions is advised. If price action strengthens and the earnings path confirms stabilization, a ramp toward the median target could justify a closer-to-Buy stance.

Comprehensive data references used

  • Price targets and analyst coverage: Target low 150, median 255, high 287; current price 219.73; number of opinions 22; mean price 253.5.
  • Fundamental metrics: market cap, EV, forward P/E, price-to-book, ROA, margins, cash/debt, beta.
  • Recent earnings: quarterly net income and EPS—observations of negative earnings in 2024/2025 quarters (with some improvement into 2025-06-30), and near-term negative to slightly positive EPS signals.
  • EPS trend: current negative EPS with signs of potential improvement in the +1q and +1y figures.
  • EPS revisions: nearly all recent revisions show downgrades in the near term; modest upside indicated in the far term (+1y).

Table: Key Metrics (selected)

  • Current price: 219.73
  • Market cap: 167,018,528,768
  • Enterprise value: 196,950,917,120
  • Forward P/E: 467.51
  • Price to book: -50.29
  • ROA: -3.73%
  • Profit margins: -14.18%
  • Gross margins: -0.15%
  • Operating margins: -0.98%
  • Total cash: 22,257,999,872
  • Total debt: 55,646,999,528
  • Five-year avg dividend yield: 2.48%
  • Beta: 1.47

Table: Analyst Targets and Coverage

  • Current price: 219.73
  • Target low: 150.00
  • Target median: 255.00
  • Target high: 287.00
  • Target mean: 253.50
  • Number of analysts: 22

Table: Recent Earnings Summary (selected)

  • 2025-06-30: Net income -611,000,000; Diluted EPS -0.92
  • 2025-03-31: Net income -37,000,000; Diluted EPS -0.16
  • 2024-12-31: Net income -3,865,000,000; Diluted EPS -5.46
  • 2024-09-30: Net income -6,170,000,000; Diluted EPS -9.97
  • 2024-06-30: Net income -1,439,000,000; Diluted EPS -2.33

Table: EPS Trend (selected)

  • 0q: -0.99774
  • +1q: 0.00346
  • 0y: -2.66529
  • +1y: 3.56791

Table: EPS Revisions (selected)

  • 0q: Up Last 7d: 0; Up Last 30d: 0; Down Last 30d: 5; Down Last 7d: 1
  • +1q: Up Last 7d: 0; Up Last 30d: 1; Down Last 30d: 3; Down Last 7d: 1
  • 0y: Up Last 7d: 0; Up Last 30d: 0; Down Last 30d: 5; Down Last 7d: 1
  • +1y: Up Last 7d: 1; Up Last 30d: 0; Down Last 30d: 3; Down Last 7d: 0

Note: All numbers are presented in USD unless otherwise indicated. Forward-looking targets are inherently uncertain and depend on multiple macro and company-specific factors. The horizontal lines drawn reflect the specified low, median, and high price targets and extend approximately 30 days beyond today to visualize potential future price fronts.

If you’d like, I can adjust the color scheme, extend the target lines to a different horizon, or add a sensitivity analysis showing how small changes in EPS growth or defense-spend assumptions would impact the upside to each target.

Chart is loading...